341 related articles for article (PubMed ID: 34564058)
1. Simultaneous determination of dacomitinib and its major metabolite, O-desmethyl dacomitinib in human plasma by LC-MS/MS and its application to clinical testing in patients with non-small cell lung cancer.
Feng X; Ding Y; Zhang P; Fu Q; Zhang L; Zheng H
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Oct; 1182():122940. PubMed ID: 34564058
[TBL] [Abstract][Full Text] [Related]
2. Quantitative bioanalytical assay for the human epidermal growth factor receptor (HER) inhibitor dacomitinib in rat plasma by UPLC-MS/MS.
Qiu X; Lin Q; Ning Z; Qian X; Li P; Ye L; Xie S
J Pharm Biomed Anal; 2019 Mar; 166():66-70. PubMed ID: 30612075
[TBL] [Abstract][Full Text] [Related]
3. Development of an LC-MS/MS method for quantifying ASK120067, a novel mutant-selective inhibitor of the epidermal growth factor receptor (EGFR) as well as its main metabolite in human plasma and its application in a pharmacokinetic study.
Cui X; Wang S; Gao H; Li B; Shi Y; Guo H; Song T; Zheng X
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1162():122488. PubMed ID: 33360679
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous and rapid determination of 12 tyrosine kinase inhibitors by LC-MS/MS in human plasma: Application to therapeutic drug monitoring in patients with non-small cell lung cancer.
Zhou L; Wang S; Chen M; Huang S; Zhang M; Bao W; Bao A; Zhang P; Guo H; Liu Z; Xie G; Gao J; Wu Z; Lou Y; Fan G
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1175():122752. PubMed ID: 33991955
[TBL] [Abstract][Full Text] [Related]
5. Development of an LC-MS/MS method for quantifying two main metabolites of abivertinib in human plasma.
Zheng X; Wang W; Zhang Y; Ma Y; Zhao H; Gao H; Hu P; Jiang J
Biomed Chromatogr; 2020 Feb; 34(2):e4704. PubMed ID: 31629371
[TBL] [Abstract][Full Text] [Related]
6. Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patients.
Reis R; Labat L; Allard M; Boudou-Rouquette P; Chapron J; Bellesoeur A; Thomas-Schoemann A; Arrondeau J; Giraud F; Alexandre J; Vidal M; Goldwasser F; Blanchet B
J Pharm Biomed Anal; 2018 Sep; 158():174-183. PubMed ID: 29883880
[TBL] [Abstract][Full Text] [Related]
7. Validation of a sensitive simultaneous LC-MS/MS method for the quantification of novel anti-cancer thiazolidinedione and quinazolin-4-one derivatives in rat plasma and its application in a rat pharmacokinetic study.
Sengottuvelan S; Uppal R; Vuppu S
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1121():18-27. PubMed ID: 31082683
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of alflutinib and its active metabolite in human plasma using liquid chromatography-tandem mass spectrometry.
Liu X; Li W; Zhang Y; Jiang Y; Zhao Q; Zhong D
J Pharm Biomed Anal; 2019 Nov; 176():112735. PubMed ID: 31394305
[TBL] [Abstract][Full Text] [Related]
9. Rapid determination of gefitinib and its main metabolite, O-desmethyl gefitinib in human plasma using liquid chromatography-tandem mass spectrometry.
Wang LZ; Lim MY; Chin TM; Thuya WL; Nye PL; Wong A; Chan SY; Goh BC; Ho PC
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2155-61. PubMed ID: 21703945
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous quantitation of befotertinib (D-0316) and its metabolite D-0865 in human plasma by LC-MS/MS method.
Li H; Wang Y; Ding R; Chen C; Tian Z; Yin H; Ding L
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jan; 1214():123499. PubMed ID: 36525886
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a UPLC-MS/MS method for quantification of C-005, a novel third-generation EGFR TKI, and its major metabolite in plasma: Application to its first-in-patient study.
Wang Z; Ye W; Qin Y; You H; Zhang S; Fan F; Wang Y; Zheng L
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1162():122475. PubMed ID: 33370688
[TBL] [Abstract][Full Text] [Related]
13. A validated UPLC-MS/MS method for the determination of CX3002 in human plasma and its application to a pharmacokinetic study.
Hu X; Xu Y; Chen J; Shen Y; Yang D; Hu Y; Jiang B; Lou H; Ruan Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Oct; 1183():122954. PubMed ID: 34628186
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination and determination of sildenafil and its active metabolite in human plasma using LC-MS/MS method.
Li LL; Zhang XJ; Zheng C; Fan MX; Xu HY; Yi JL; Feng Y; Luo X; Li WH; Cheng ZN
Biomed Chromatogr; 2020 Oct; 34(10):e4927. PubMed ID: 32562289
[TBL] [Abstract][Full Text] [Related]
15. UPLC-MS/MS for the Simultaneous Determination of Sildenafil and N-Desmethyl Sildenafil.
Zhu WL; Zheng C; Xiong WG; Chen CL; Yi JL; Zhang XJ; Luo X
J Chromatogr Sci; 2021 Sep; 59(9):823-829. PubMed ID: 33517421
[TBL] [Abstract][Full Text] [Related]
16. LC-MS-MS determination of imatinib and N-desmethyl imatinib in human plasma.
Zhang Y; Qiang S; Yu Z; Zhang W; Xu Z; Yang L; Wen A; Hang T
J Chromatogr Sci; 2014 Apr; 52(4):344-50. PubMed ID: 23574742
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of glimepiride and pioglitazone in human plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic study.
Ni XJ; Wang ZZ; Shang DW; Zhang M; Hu JQ; Qiu C; Wen YG
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():247-52. PubMed ID: 24835512
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of idelalisib and its metabolite GS-563117 in dog plasma by LC-MS/MS: Application to a pharmacokinetic study.
Wang C; Jia F; Zhang Y
Biomed Chromatogr; 2019 May; 33(5):e4511. PubMed ID: 30773664
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of flumatinib and its two major metabolites in plasma of chronic myelogenous leukemia patients by liquid chromatography-tandem mass spectrometry.
Yang Y; Liu K; Zhong D; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():25-30. PubMed ID: 22472641
[TBL] [Abstract][Full Text] [Related]
20. Development and validation a LC-MS/MS method for the simultaneous determination of agomelatine and its metabolites, 7-desmethyl-agomelatine and 3-hydroxy-agomelatine in human plasma: Application to a bioequivalence study.
Li M; Tang F; Xie F; Lv Y; Yu P; Liu Z; Cheng Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1003():60-6. PubMed ID: 26409931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
